University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60ml

Phase 4

Completed

Conditions: Induction of Labor

Interventions: Procedure: Induction of labor with foley balloon - 60cc of saline
Procedure: Induction of labor with foley balloon with 30cc

First Posted Date: 2007-03-23

Last Posted Date: 2013-08-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 192

Registration Number: NCT00451308

Locations: 🇺🇸
University of California, San Francisco Department of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California, United States

Anti-Retrovirals for Kaposi's Sarcoma

Phase 4

Completed

Conditions: Kaposi's Sarcoma
HIV Infections

Interventions: Drug: Lopinavir/ritonavir plus Emtricitabine/Tenofovir versus Efavirenz plus Emtricitabine/Tenofovir

First Posted Date: 2007-03-07

Last Posted Date: 2014-08-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 224

Registration Number: NCT00444379

Locations: 🇺🇬
Infectious Diseases Institute, Mulago Hospital, Kampala, Uganda

Study of Ductal Lavage in Women at High Risk for Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2007-02-01

Last Posted Date: 2012-09-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT00429988

Locations: 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors
Lymphoma

Interventions: Biological: rituximab

First Posted Date: 2006-12-28

Last Posted Date: 2015-02-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT00416923

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: fluvastatin sodium
Procedure: Breast Cancer Surgery Only - Arm III

First Posted Date: 2006-12-28

Last Posted Date: 2012-12-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 35

Registration Number: NCT00416403

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 1 locations

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Not Applicable

Completed

Conditions: Brain and Central Nervous System Tumors
Lymphoma

Interventions: Biological: filgrastim
Biological: rituximab
Drug: cytarabine
Drug: etoposide phosphate
Drug: leucovorin calcium
Drug: methotrexate
Drug: temozolomide

First Posted Date: 2006-12-28

Last Posted Date: 2015-08-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT00416819

Educational Program to Improve Heart Failure Outcomes in Adults Living in Rural Areas

Phase 3

Completed

Conditions: Heart Failure, Congestive

Interventions: Behavioral: Fluid Watchers LITE Educational Intervention
Behavioral: Fluid Watchers PLUS Educational Intervention

First Posted Date: 2006-12-25

Last Posted Date: 2013-06-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 614

Registration Number: NCT00415545

Locations: 🇺🇸
University of California, Davis, Davis, California, United States
🇺🇸
Washoe Health Care System, Reno, Nevada, United States
🇺🇸
University of Kentucky, Lexington, Kentucky, United States

Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease

Not Applicable

Terminated

Conditions: Fibrotic Interstitial Lung Disease

First Posted Date: 2006-12-22

Last Posted Date: 2008-01-15

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00415272

Locations: 🇺🇸
University of California at San Francisco, San Francisco, California, United States

Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery

Phase 1

Terminated

Conditions: Pancreatic Cancer

First Posted Date: 2006-12-13

Last Posted Date: 2012-09-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT00410774

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Dietary Supplement: lycopene supplement
Dietary Supplement: fish oil supplement
Other: Placebo

First Posted Date: 2006-11-22

Last Posted Date: 2016-01-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 84

Registration Number: NCT00402285

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy